Home

Tänzer Die Gäste heroisch nmd pharma claus olesen Delikatesse empfehlen Zilien

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

NMD Pharma
NMD Pharma

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

NMD Pharma
NMD Pharma

UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular  Disease Mentor 1 Pontus Gourdon, MSc & PhD,
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Initiator Pharma
Initiator Pharma

Initiator Pharma
Initiator Pharma

Well-financed biotech company to enter the clinic in 2020
Well-financed biotech company to enter the clinic in 2020

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Company Presentation
Company Presentation

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

Claus Elsborg Olesen - Biography
Claus Elsborg Olesen - Biography

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Initiator Pharma | LinkedIn
Initiator Pharma | LinkedIn

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

Prominent Canadian researcher in Denmark: Why I left a top job in California
Prominent Canadian researcher in Denmark: Why I left a top job in California

NMD Pharma to advance neuromuscular disorder therapies with €38m Series A  round
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

Company Presentation
Company Presentation

AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders -  The Lens - Free & Open Patent and Scholarly Search
AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders - The Lens - Free & Open Patent and Scholarly Search